Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The aim of this study is to investigate the diagnostic efficiency of gastrin, pepsinogen, proinflammatory cytokines (TNF-α, IL-6), and oxidative stress biomarkers in horses with equine gastric ulcer syndrome (EGUS). Thirty horses diagnosed with gastroscopic EGUS and 15 clinically healthy horses were selected for this study. The serum levels of gastrin, pepsinogen showed nonsignificant changes in horses with EGUS when compared with healthy horses. The serum levels of TNF-α, IL-6 revealed a significant increase in horses with EGUS when compared with healthy ones. Oxidative stress is evident in horses with EGUS in comparison with healthy horses as detected by higher levels of malondialdehyde (MDA) and decreased serum levels of total antioxidant capacity (TAC), Superoxide dismutase (SOD), glutathione (GSH), and nitric oxide (NO). MDA and TNF-α showed better sensitivity and specificity than IL-6 in distinguishing horses with EGUS from control horses. Conclusively, examination of serum gastrin and pepsinogen levels had a limited value in diagnosis of EGUS in horses under investigation. Moreover, this study showed that oxidative stress is evident in horses with EGUS. Higher levels of TNF-α and IL-6 indicate their role in EGUS pathogenesis in horses. Finally, MDA, TNF-α, and IL-6 could be used as biological markers for preliminary screening of horses with EGUS. Gastroscopy still accredited as the "gold standard" for diagnosis EGUS.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jevs.2019.102853DOI Listing

Publication Analysis

Top Keywords

horses egus
24
tnf-α il-6
16
horses
14
egus
12
gastrin pepsinogen
12
oxidative stress
12
healthy horses
12
serum levels
12
equine gastric
8
gastric ulcer
8

Similar Publications

Background: It is unknown whether the high prevalence of Equine Squamous (ESGD) and Equine Glandular (EGGD) Gastric Disease in extensively grazed Icelandic horses in the autumn/winter is seasonally driven.

Objectives: To determine the prevalence of, and risk factors for, gastroscopically significant ESGD (ESGD:score of ≥2/4); gastroscopically severe ESGD (ESGD:score of ≥3/4) and gastroscopically significant EGGD (EGGD:score of ≥1/2) in extensively pasture-managed Icelandic horses at four timepoints.

Study Design: Prospective longitudinal cohort.

View Article and Find Full Text PDF

Cytoplasmic and nuclear Survivin expression in healthy gastric mucosae of equids: A comparative study between horses, donkeys, and mules.

J Equine Vet Sci

October 2025

Equine Medicine and Surgery Research Line (LIMCE), CENTAURO Research Group, School of Veterinary Medicine, Faculty of Agricultural Sciences, University of Antioquia, Medellin 050010, Colombia.

Background: Information regarding Survivin protein expression in the gastric mucosa of equids is scarce. This protein has been associated with functions related to modulating apoptosis and promoting mitosis in epithelial cells and is considered part of gastric cytoprotection mechanisms in humans and mice, maintaining mucosal integrity and regulating cellular renewal.

Aims/objectives: This study aimed to determine the expression of cytoplasmic and nuclear Survivin in gastric mucosae of equids (horses, donkeys, and mules).

View Article and Find Full Text PDF

Assessment of Salivary Biomarkers of Gastric Ulcer in Horses from a Clinical Perspective.

Animals (Basel)

July 2025

Department of Animal Medicine and Surgery, Regional Campus of International Excellence "Campus Mare Nostrum", University of Murcia, Espinardo, 30100 Murcia, Spain.

This study arises from the search for non-invasive diagnostic alternatives for equine gastric ulceration (EGUS), which is prevalent, clinically variable and only confirmed by gastroscopy. The aim is to quantify five salivary biomarkers (IL1-F5, PIP, CA VI, serotransferrin, albumin) under clinical conditions by validated assays and analyse their diagnostic value. Horses were grouped in No EGUS (neither clinical signs of EGUS nor gastric lesions), EGUS non-clinical (apparently no clinical signs of EGUS but with gastric lesions), and EGUS clinical (obvious clinical signs of EGUS and with gastric lesions).

View Article and Find Full Text PDF

Background: Phenylbutazone (PBZ) can potentially induce gastrointestinal ulceration, and early detection of PBZ-induced gastroenteropathy will be useful for the diagnosis, treatment, and prevention of PBZ toxicity.

Objectives: To identify putative proteins associated with equine gastric ulcer syndrome after clinical dose (4.4 mg/kg) administration of PBZ by proteomic study.

View Article and Find Full Text PDF

Equine gastric ulceration syndrome (EGUS) is a common condition, affecting both glandular (EGGD) and squamous (ESGD) mucosa of the stomach. It has a high prevalence, particularly in racehorses and sport horses, causing clinical signs from poor performance to colic. Gastroscopy, the reference standard diagnostic method, is expensive, prompting the search for alternative tests.

View Article and Find Full Text PDF